Abbisko Cayman Limited (HKG:2256)
Hong Kong · Delayed Price · Currency is HKD 13.11
+0.21 (1.63%)
Dec 30, 2025, 4:08 PM HKT
Abbisko Cayman Market Cap
Abbisko Cayman has a market cap or net worth of 8.81 billion as of December 30, 2025. Its market cap has increased by 196.79% in one year.
Market Cap
8.81B
Enterprise Value
6.34B
Revenue
678.11M
Ranking
n/a
PE Ratio
53.72
Stock Price
13.11
Market Cap Chart
Since October 15, 2021, Abbisko Cayman's market cap has increased from 8.71B to 8.81B, an increase of 1.19%. That is a compound annual growth rate of 0.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 8.81B | 206.47% |
| Dec 31, 2024 | 2.88B | 21.63% |
| Dec 29, 2023 | 2.36B | 4.97% |
| Dec 30, 2022 | 2.25B | -64.77% |
| Dec 31, 2021 | 6.39B | -26.60% |
| Oct 15, 2021 | 8.71B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 268.64B |
| Hansoh Pharmaceutical Group Company | 226.54B |
| JD Health International | 187.74B |
| Innovent Biologics | 138.95B |
| WuXi Biologics | 134.58B |
| Sino Biopharmaceutical | 114.77B |
| Akeso | 103.72B |
| CSPC Pharmaceutical Group | 100.27B |